about
Data from regulatory studies: What do they tell? What don't they tell?Oxcarbazepine in the treatment of epilepsy.Women and epilepsy: review and practical recommendations.Birth outcomes after prenatal exposure to antiepileptic drugs--a population-based study.Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in Finland.Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States.
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Special considerations for women with epilepsy.
@ast
Special considerations for women with epilepsy.
@en
type
label
Special considerations for women with epilepsy.
@ast
Special considerations for women with epilepsy.
@en
prefLabel
Special considerations for women with epilepsy.
@ast
Special considerations for women with epilepsy.
@en
P2860
P1433
P1476
Special considerations for women with epilepsy.
@en
P2093
P2860
P304
P356
10.1592/PHCO.20.12.159S.35249
P407
P433
P577
2000-08-01T00:00:00Z